Summer 2016
 
FASD Education and Outreach Projects
Newsletter

In This Issue

Join Our Mailing List

 

 E-mail us at:

WTOP@fammed.wisc.edu 

 

Link to WTOP Website
(Please scan with a Smart Phone)
  
Education and Outreach Project Updates
Happy Summer to all our followers! We hope everyone is enjoying the sunshine, warm weather and summertime activities. We continue to have many exciting opportunities this year, including TWO new trainings that are coming up quickly!  

Substance Use in Pregnancy (webinar) is August 16 , and Modifying Treatment for Adolescents and Adults with FASD is September 26 . Scroll down to learn more, or contact Lindsey Peterson at 608-265-6392 to sign up for the trainings.

                     

If you have any trainings needs or have any other questions, please contact us!
 
Sincerely, 
FASD Education and Outreach Projects Team   

Ask a Doc
doctors2.jpg 
 
This column features "Frequently Asked Questions" related to the prevention, identification and treatment of fetal alcohol spectrum disorders from our trainings, email or phone inquiries. With all of the conflicting information available on the web, we'll try hard to find experts to best answer your questions. You can email us directly (WTOP@fammed.wisc.edu), or call us (608-265-6392) with your questions.
 
QUESTION:

What happens during the two weeks before zygote implantation? Can alcohol affect whether or not the zygote attaches to the uterus?

ANSWER: 

Yes.  Among others, a study published last year ("Dose effect of gestational ethanol exposure on placentation and fetal growth" by F Gundogan and colleagues in
Placenta Volume 36, Issue 5, May 2015, Pages 523-530) showed that alcohol exposure during early placental development can impair the mobility and invasiveness of placental cells, resulting in reduced attachment to the wall of the uterus. 
 
Your first broader question is also very important.  Traditionally, the first 2 weeks after conception have been regarded as an "all or none" window; it is believed that if there is a toxic effect on the embryo from alcohol exposure during that time it will result in loss of the embryo, and that embryos which survive will not show effects. While loss of the embryo is certainly an effect, it is not one that results in the birth of a child with an FASD, and so at least from that perspective those first 2 weeks have been regarded as a relatively "safe" window for exposure.  However, we are also learning that a tremendous amount of important activity is happening at the genetic level during that early period of embryonic development.  Much of the epigenetic programming that will later turn genes on and off at the right times is being set up during that time.  We also know that alcohol has a number of potent effects on gene expression.  The dots here have not quite been connected yet, but together this information suggests that we may someday find that exposures during the first 2 weeks after conception are actually important and may pose more risk for the development of FASD than we have traditionally thought.

David Wargowski MD
Professor, Department of Pediatrics
Chief, Division of Genetics and Metabolism
University of Wisconsin School of Medicine and Public Health
Facts : Informativas
Each quarter we will share a new fact with our readers in both English and Spanish. For more information, click on the link below.  
  •  Contraceptive use among adolescents is increasing in many countries, as is age at first marriage. Rates of adolescent childbearing have also dropped significantly in many countries and regions over the last few decades.
  • E l uso de anticonceptivos entre los adolescentes está aumentando en muchos países, igual como la edad del primer matrimonio. Las tasas de embarazo en la adolescencia también han disminuido considerablemente en muchos países y regiones a lo largo de las últimas décadas.
Hot off the Press!
Coming Up:
September 9 is FASD Awareness Day!

In addition to September 9, 2016 being FASD Awareness Day, the whole month of September is also considered FASD Awareness Month, in commemoration of the nine months of pregnancy. Click here  to find out more about FASD Awareness Month from the Centers for Disease Control and Prevention (CDC).
<><><><><><><><><><><><><><><><><><><><><>

When Parents Use Substances: What Pediatricians Need to Know


<><><><><><><><><><><><><><><><><><><><><>

Substance Use Screening, Brief Intervention, and Referral to Treatment
Click here to view the article

<><><><><><><><><><><><><><><><><><><><><>

Upcoming Trainings and Conferences
Substance Use in Pregnancy Webinar

When:
Tuesday, August 16, 2016
1:00 PM - 2:00 PM CST
Who:
Randall Brown, MD, PhD, FASAM
Associate Professor
Department of Family Medicine and Community Health
Conducted by:
FASD Education and Outreach Projects
Department of Family Medicine and Community Health
School of Medicine and Public Health, University of WI
Hosted by:
Great Lakes Addiction Technology Transfer Center Network
Contact:
Please click here for registration information.

Adapting Treatment for Adolescents and Adults with FASD

When:
Monday, September 26, 2016
8:30 AM - 3:00 PM
Who:
Dan Dubovsky
FASD Consultant/Trainer
Where:
St. Mary's Hospital
Conference Room 6
700 South Park Street
Madison, WI
Conducted by:
FASD Education and Outreach Projects
Department of Family Medicine and Community Health
School of Medicine and Public Health,  University of WI
Contact:
Please click here to view the flyer, and contact Lindsey Peterson at 608-265-6392 or lindsey.peterson@fammed.wisc.edu to register.

12th Annual Mental Health and Substance Use Recovery Conference

When:
October 26 and 27, 2016
Where:
Kalahari Convention Center and Resort
Wisconsin Dells, WI
Contact:
Registration information will be coming soon!
Please click here for conference and registration information.

<><><><><><><><><><><><><><><><><><><><>
Please contact us with your questions or training needs at: lindsey.peterson@fammed.wisc.edu 
About Us

Wisconsin FASD Education and Outreach Projects  


 

Wisconsin FASD Education and Outreach Projects focus on addressing the prevention, identification, and treatment of Fetal Alcohol Spectrum Disorders (FASD).  

For more specific project information, see below:

 

 

The Wisconsin FASD Treatment Outreach Project (WTOP) provides training and consultation on fetal alcohol spectrum disorders (FASD), clinical assessment of individuals at risk, and support to professionals to work with individuals with FASD. We understand alcohol use during pregnancy and FASD are sensitive issues. The WTOP team is prepared to discuss these topics with concerned women and families in a culturally competent and trauma informed manner to educate and provide resources and support. Some women and families may have heard about FASD in their day to day lives. If they consumed alcohol during pregnancy and have children with learning and/or behavior problems, an assessment is the first step in identifying appropriate referrals, services and interventions for both mother and child. 

 

The University of Wisconsin Department of Family Medicine and Community Health (DFMCH) was awarded a cooperative agreement, Advancing Alcohol Screening and Brief Intervention (aSBI) and CHOICES in American Indian and Alaska Native Populations through by the Centers for Disease Control and Prevention (CDC) in August 2013. The overarching goal of the project is twofold: (1) to demonstrate capacity by DFMCH to provide culturally appropriate training and technical assistance to implement and sustain aSBI/CHOICES services in Tribal clinics serving a patient population that is primarily Native American; and (2) to reduce risky drinking and the risk of an alcohol-exposed pregnancy in the identified patient population. Booshké giin is the collaborative program name chosen by our tribal partners to represent this project; it means to decide or to make a choice. 

 

The Juvenile Justice Alcohol and Other Drug Abuse Program's purpose is to create and improve community efforts to increase screening, intervention and treatment of juvenile alcohol and drug problems for Wisconsin's at-risk youth population. Collaboration with the Wisconsin Fetal Alcohol Spectrum Disorder (FASD) Treatment Outreach Project (WTOP) is to provide training and consultation on fetal alcohol spectrum disorders clinical assessment of women and children at risk, and support to professionals to work with individuals with FASD.


The primary purpose of the FASD Practice and Implementation Center for Pediatrics (PIC) is to develop, test and disseminate innovative training for pediatricians in training and in practice to increase capacity to diagnose the full spectrum of disorders associated with prenatal alcohol exposure.

 

Contact
Georgiana Wilton, PhD, Principal Investigator
Angelica Salinas, MS, CRC, Project Director
Lindsey Peterson, MS, CRC, Outreach Specialist
Barbara Vardalas, MA, Evaluator

University of Wisconsin School of Medicine and Public Health
Department of Family Medicine and Community Health
1100 Delaplaine Court
Madison, WI 53715
608-262-6590
  
Stay Connected!